StockData

WINDWARD BIO GROUP AG (WWB) company profile

WWBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$22.64−3.12 (-12.11%)

Close on Nov 18, 2026Market cap –P/E –Yield –

About Windward Bio

Biological Products, (No Diagnostic Substances), SIC 2836

WINDWARD BIO GROUP AG is listed on Nasdaq under the ticker WWB, in the SEC industry Biological Products, (No Diagnostic Substances). It is incorporated in V8 and its fiscal year ends on December 31.

Company profile

Company

Legal name
WINDWARD BIO GROUP AG
Industry
Biological Products, (No Diagnostic Substances)
Incorporated in
V8
Fiscal year ends
December 31

Stock & identifiers

Ticker
WWB
Exchange
Nasdaq
SEC CIK
2145089
FIGI
BBG0268LL8F2
Share class FIGI
BBG0268LL9F0
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Luca SantarelliChief Executive Officer, Director4,578,110
Scott ApplebaumChief Legal & Corp Dev Officer960,966
Claudia D'AugustaChief Financial Officer927,760
Kevin Andrew HarrisChief Operating Officer960,966
Omar KhwajaChief Medical Officer642,136
Advisors Llc OrbimedDirector7,097,483
Capital GP IX LLC OrbiMedDirector–
Otello StampacchiaDirector5,338,520
David P. BonitaDirector7,097,483
Iqbal Rasool MuftiDirector–
Sandip KapadiaDirector100,000

Corporate history

Events identified from SEC filings

See a number that looks wrong?